Framatome acquired Valinox Nucleaire S.A.S. from Vallourec S.A. (ENXTPA:VK) for 12 million on May 31, 2021. Valinox becomes a subsidiary of Framatome and retains its brand name. All required regulatory approvals and authorizations have been obtained and employee representative bodies have been consulted, making this transaction possible. Alexandre de Verdun of Jones day acted as legal advisor to Framatome.
Framatome completed the acquisition of Valinox Nucleaire S.A.S. from Vallourec S.A. (ENXTPA:VK) on May 31, 2021.